These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9098189)

  • 1. Compounding language drafted by congress.
    Nichols D
    J Nucl Med; 1997 Apr; 38(4):23N-24N. PubMed ID: 9098189
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacy compounding: background on the latest federal initiatives.
    Nichols D
    J Nucl Med; 1998 Jan; 39(1):26N. PubMed ID: 9443726
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Judge allows bulk ingredients for compounding: ruling favors pharmacy, but FDA can still distinguish manufacturing, compounding.
    Cima G
    J Am Vet Med Assoc; 2011 Nov; 239(10):1266-68. PubMed ID: 22044321
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacist compounding vs veterinarian compounding: similarities and differences.
    Jordan DG
    J Am Vet Med Assoc; 1994 Jul; 205(2):256-60. PubMed ID: 7928593
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of federal law to compounding of prescription orders.
    Breaux PJ
    J La State Med Soc; 1998 Jun; 150(6):275-8. PubMed ID: 9677787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal restrictions on compounding.
    Geyer RE
    J Am Vet Med Assoc; 1994 Jul; 205(2):241-2. PubMed ID: 7928588
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 9. Dilemmas in compounding for the veterinary teaching hospital.
    Kemp DT
    J Am Vet Med Assoc; 1994 Jul; 205(2):263-7. PubMed ID: 7928595
    [No Abstract]   [Full Text] [Related]  

  • 10. Compounding pharmacy oversight moves ahead.
    Traynor K
    Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment of a nuclear pharmacy.
    Porter WC; Ice RD; Hetzel KR
    Am J Hosp Pharm; 1975 Oct; 32(10):1023-7. PubMed ID: 1190214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians pan FDA plan for PET.
    Rojas-Burke J
    J Nucl Med; 1993 Apr; 34(4):26N, 30N. PubMed ID: 8455071
    [No Abstract]   [Full Text] [Related]  

  • 13. Court files order in pharmacies' case against FDA.
    J Am Vet Med Assoc; 2006 Oct; 229(8):1228. PubMed ID: 17066572
    [No Abstract]   [Full Text] [Related]  

  • 14. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 16. Expectations of the public regarding pharmaceuticals.
    Archambault GF
    Environ Health Ser Radiol Health; 1967 Dec; 30():105-13. PubMed ID: 5600630
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 18. Final guidance for pharmacy compounding of human drug products under Section 503A.
    Blankenship CE
    Int J Pharm Compd; 2014; 18(5):379-80. PubMed ID: 25577886
    [No Abstract]   [Full Text] [Related]  

  • 19. The Home Field Disadvantage.
    Cabaleiro J
    Int J Pharm Compd; 2016; 20(1):86-7. PubMed ID: 27125059
    [No Abstract]   [Full Text] [Related]  

  • 20. Congress passes FDA reform act: nuclear medicine community stands to gain.
    Kotz D
    J Nucl Med; 1998 Jan; 39(1):15N-16N, 18N. PubMed ID: 9443722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.